We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

MEmbranous Nephropathy Trial Of Rituximab (MENTOR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01180036
Recruitment Status : Active, not recruiting
First Posted : August 11, 2010
Last Update Posted : February 23, 2018
Information provided by (Responsible Party):
Fernando Fervenza, Mayo Clinic